- KR₩1tn
- KR₩881bn
- KR₩474bn
Brief: Seegene Q4 Operating Profit 7 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Establishes French Subsidiary To Expand European Footprint
Brief: Seegene Q2 Operating Profit 3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q1 Operating Profit 14.8 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Q4 Operating Loss 6.2 Billion Won
Brief: Seegene Q3 Operating Profit 5.3 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Inc Expands Mpox Ruo Product Lineups With Enhanced Detection Assays For Clade 1
Brief: Seegene Q2 Operating Loss 1 Billion Won
Brief: Seegene To Divest 2.7 Billion Won Worth Of Own Shares
Brief: Seegene Q1 Operating Loss 14 Billion Won
Brief: Seegene Q4 Operating Profit 3.5 Billion Won, Down 78.4% From Year Earlier
Brief: Seegene Q4 Operating Profit 5 Billion Won, Swings To Profit From Year Earlier
Brief: Seegene Announces Collaboration With Microsoft To Realize 'A World Free From All Diseases'
Brief: Seegene Q3 Operating Loss 10 Billion Won, Up 69% From Year Earlier
Brief: Seegene Q2 Operating Loss 9.7 Billion Won, Swings To Loss From Year Earlier
South Korea biopharma stocks jump on rising COVID cases
Brief: Seegene Inc and Werfen Partner To Collaborate On Onesystem Business To Develop Syndromic QPCR Assays
Brief: Seegene Q1 Operating Loss 13.8 Billion Won, Swings To Loss From Year Earlier
Brief: Seegene Inc Q4 Operating Profit 16 Billion Won, Down 92% From Year Earlier